ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

被引：856

作者：

Colombo, N. ^{[1
,2
]}

Creutzberg, C. ^{[3
]}

Amant, F. ^{[4
,5
]}

Bosse, T. ^{[6
]}

Gonzalez-Martin, A. ^{[7
,8
]}

Ledermann, J. ^{[9
]}

Marth, C. ^{[10
]}

Nout, R. ^{[11
]}

Querleu, D. ^{[12
,13
]}

Mirza, M. R. ^{[14
]}

Sessa, C. ^{[15
]}

机构：

[1] European Inst Oncol, Div Med Gynecol Oncol, Milan, Italy

[2] Univ Milano Bicocca, Milan, Italy

[3] Leiden Univ, Dept Radiat Oncol, Med Ctr, Leiden, Netherlands

[4] Univ Hosp Leuven, Dept Gynecol Oncol, Leuven, Belgium

[5] Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands

[6] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands

[7] GEICO Canc Ctr, Dept Med Oncol, Madrid, Spain

[8] MD Anderson Canc Ctr, Dept Med Oncol, Madrid, Spain

[9] UCL Canc Inst, Dept Oncol & Canc Trials, London, England

[10] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria

[11] Leiden Univ, Dept Radiotherapy, Med Ctr, Leiden, Netherlands

[12] Inst Bergonie, Dept Surg, Bordeaux, France

[13] McGill Univ, Dept Obstet & Gynecol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada

[14] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark

[15] Osped San Giovanni Bellinzona, Oncol Inst Southern Switzerland, Dept Med Oncol, Bellinzona, Switzerland

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷 / 01期

关键词：

endometrial neoplasms; practice guideline; consensus; treatment; adjuvant; surgery; PHASE-III TRIAL; LYMPHVASCULAR SPACE INVOLVEMENT; FERTILITY-SPARING-MANAGEMENT; POSTOPERATIVE RADIATION-THERAPY; WHOLE-ABDOMINAL-IRRADIATION; EXTERNAL-BEAM RADIOTHERAPY; UTERINE SEROUS CARCINOMA; INDEPENDENT RISK-FACTOR; CLINICAL STAGE-I; CLEAR-CELL;

D O I：

10.1093/annonc/mdv484

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.

引用

页码：16 / 41

页数：26

共 213 条

[1] Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Aapro, MS
van Wijk, FH
Bolis, G
Chevallier, B
van der Burg, MEL
Poveda, A
de Oliveira, CF
Tumolo, S
di Palumbo, VS
Piccart, M
Franchi, M
Zanaboni, F
Lacave, AJ
Fontanelli, R
Favalli, G
Zola, P
Guastalla, JP
Rosso, R
Marth, C
Nooij, M
Presti, M
Scarabelli, C
Splinter, TAW
Ploch, E
Beex, LVA
Huinink, WT
Forni, M
Melpignano, M
Blake, P
Kerbrat, P
Mendiola, C
Cervantes, A
Goupil, A
Harper, PG
Madronal, C
Namer, M
Scarfone, G
Stoot, JEGM
Teodorovic, I
Coens, C
Vergote, I
Vermorken, JB
[J]. ANNALS OF ONCOLOGY, 2003, 14 (03) : 441 - 448
[2] Sentinel Lymph Node Mapping for Endometrial Cancer: A Modern Approach to Surgical Staging
Abu-Rustum, Nadeem R.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (02): : 288 - 297
[3] The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes
Abu-Rustum, Nadeem R.
Gomez, Jacob D.
Alektiar, Kaled M.
Soslow, Robert A.
Hensley, Martee L.
Leitao, Mario M., Jr.
Gardner, Ginger J.
Sonoda, Yukio
Chi, Dennis S.
Barakat, Richard R.
[J]. GYNECOLOGIC ONCOLOGY, 2009, 115 (02) : 236 - 238
[4] Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study
Aghajanian, Carol
Sill, Michael W.
Darcy, Kathleen M.
Greer, Benjamin
McMeekin, D. Scott
Rose, Peter G.
Rotmensch, Jacob
Barnes, Mack N.
Hanjani, Parviz
Leslie, Kimberly K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) : 2259 - 2265
[5] WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma
Al-Hussaini, M
Stockman, A
Foster, H
McCluggage, WG
[J]. HISTOPATHOLOGY, 2004, 44 (02) : 109 - 115
[6] Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer
AlHilli, Mariam M.
Mariani, Andrea
Bakkum-Gamez, Jamie N.
Dowdy, Sean C.
Weaver, Amy L.
Peethambaram, Preema P.
Keeney, Gary L.
Cliby, William A.
Podratz, Karl C.
[J]. GYNECOLOGIC ONCOLOGY, 2014, 133 (03) : 485 - 493
[7] Reproductive Factors and the Risk of Endometrial Cancer
Ali, Aus Tariq
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (03) : 384 - 393
[8] PAX2 Loss by Immunohistochemistry Occurs Early and Often in Endometrial Hyperplasia
Allison, Kimberly H.
Upson, Kristen
Reed, Susan D.
Jordan, Carolyn D.
Newton, Katherine M.
Doherty, Jennifer
Swisher, Elizabeth M.
Garcia, Rochelle L.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (02) : 159 - 167
[9] Endometrial cancer
Amant, F
Moerman, P
Neven, P
Timmerman, D
Van Limbergen, E
Vergote, I
[J]. LANCET, 2005, 366 (9484) : 491 - 505
[10] The rationale for comprehensive surgical staging in endometrial carcinosarcoma
Amant, F
[J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (02) : 521 - 522

← 1 2 3 4 5 6 7 8 9 10 →